Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled trial

20260 citationsJournal Articlegold Open Access

Authors

ClinicalTrial.gov, NCT05081401. Registered on October 18, 2021; the record was lastupdated for study protocol version 6.0, on 06 April 2025.

Good health and well-being

Published in: BMC Infectious Diseases

Field-Weighted Citation Impact: 0.00